• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Pfizer

Pfizer

PACE International Fixed Income C PWFCX 2 Star

Last Price$9.87Day Change (%)0.10%
Open Price$9.87Day Change ($)0.01
Day Range9.87–9.8752-Week Range9.49–10.98

As of Mon 05/22/2017 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Sangamo shares jump on Pfizer collaboration, quarterly results

    Sangamo shares jump on Pfizer collaboration, quarterly results

  2. Global Pain Management Drugs Market Analysis 2011-2017 & 2021: Focus on Opioids, NSAIDs, Anti-Migraine, Anticonvulsants - Research and Markets

    Global Pain Management Drugs Market Analysis 2011-2017 & 2021: Focus on Opioids, NSAIDs, Anti-Migraine, Anticonvulsants - Research and Markets

  3. Evotec Receives Pre-Clinical Milestone as Part of Its Endometriosis Alliance with Bayer

    Evotec Receives Pre-Clinical Milestone as Part of Its Endometriosis Alliance with Bayer

  4. Miraca Life Sciences Again Expands Therapeutic Drug Monitoring with Addition of First Biosimilar Inflectra®

    Miraca Life Sciences Again Expands Therapeutic Drug Monitoring with Addition of First Biosimilar Inflectra®

  5. Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Research and Markets

    Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Research and Markets

  6. Duchenne Muscular Dystrophy Therapeutics Market Report 2017 - May Turn Into a Multi-Million Dollar Industry by the End of 2022 - Research and Markets

    Duchenne Muscular Dystrophy Therapeutics Market Report 2017 - May Turn Into a Multi-Million Dollar Industry by the End of 2022 - Research and Markets

  7. TP Therapeutics Closes $45M Series C Financing

    TP Therapeutics Closes $45M Series C Financing

  8. MARKET SNAPSHOT: U.S. Stocks Struggle For Direction As Political Uncertainty Drags

    MARKET SNAPSHOT: U.S. Stocks Struggle For Direction As Political Uncertainty Drags

  9. UPDATE: U.S. stocks struggle for direction as political uncertainty drags

    UPDATE: U.S. stocks struggle for direction as political uncertainty drags

  10. Big Pharma Licensing Trends Report (2012-16) - Key Vendors are AstraZeneca, Johnson & Johnson, Merck, Pfizer , Roche & Teva - Research and Markets

    Big Pharma Licensing Trends Report (2012-16) - Key Vendors are AstraZeneca, Johnson & Johnson, Merck, Pfizer , Roche & Teva - Research and Markets

12345

©2017 Morningstar Advisor. All right reserved.